FDA Approves Once-Daily HIV Pill Complera

The FDA has approved Gilead's Complera, a combination of the HIV drugs Truvada and Edurant. It's the second complete HIV treatment in a single, once-daily pill. The first, Atripla, was approved in 2006.

Click here to read the full story.

Post a Comment

No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.

WTVQ.com supports children's privacy rights. All persons under the age of 13 MUST have parental permission to use this website and direct parental supervision is strongly recommended.